Rhythm Pharmaceuticals

RYTM

NASDAQHealth Care

Income Statement

Total Revenue$130.13M

Gross Profit$116.76M

Operating Income$-265.51M

EBITDA$-238.61M

EBIT$-240.17M

Pre-tax Income$-196.04M

Net Income$-260.57M

Cash Equivalent$88.4M

Total Debt$3.29M

Book Value$139.58M

Book Value Per Share2.29

Return on Equity (ROE)-158.37%

Return on Assets (ROA)-66.43%

Return on Invested Capital (ROI)-94.99%

Net Profit Margin-200.27%

Current Ratio3.24

Quick Ratio3.01

Long-Term Debt / Equity0.66